Latest / Oncology Today with Dr Neil Love
Management of HER2-Altered Non-Small Cell Lung Cancer
Dr Bob Li from Memorial Sloan Kettering Cancer Center in New York City discusses the current and future roles of targeted therapy for HER2-altered non-small cell lung cancer.
CME information and select publications here.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.